# Avalo Therapeutics (AVTX) — Analyst Forecast

AVTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/avtx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 13 | 0 | 0 | 13 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 7, 2026 | HC Wainwright & Co. | Maintained | Buy | $30.00 |
| Aug 7, 2026 | Guggenheim | Maintained | Buy | $48.00 |
| Jul 6, 2026 | Leerink Partners | Initiated Coverage | Outperform | $38.00 |
| Jun 16, 2026 | BTIG | Maintained | Buy | $58.00 |
| Jun 12, 2026 | B of A Securities | Initiated Coverage | Buy | $35.00 |
| May 14, 2026 | HC Wainwright & Co. | Maintained | Buy | $35.00 |
| May 14, 2026 | Mizuho | Maintained | Outperform | $45.00 |
| May 14, 2026 | Wedbush | Maintained | Outperform | $34.00 |
| May 14, 2026 | Citizens | Maintained | Market Outperform | $55.00 |
| May 11, 2026 | Piper Sandler | Maintained | Overweight | $60.00 |
| May 6, 2026 | BTIG | Maintained | Buy | $58.00 |
| May 6, 2026 | Wedbush | Maintained | Outperform | $40.00 |
| May 6, 2026 | Citizens | Maintained | Market Outperform | $62.00 |
| Apr 13, 2026 | BTIG | Maintained | Buy | $40.00 |
| Apr 9, 2026 | Wolfe Research | Initiated Coverage | Outperform | $48.00 |
| Apr 6, 2026 | Citizens | Initiated Coverage | Market Outperform | $52.00 |
| Mar 25, 2026 | HC Wainwright & Co. | Maintained | Buy | $40.00 |
| Mar 24, 2026 | BTIG | Maintained | Buy | $40.00 |
| Feb 2, 2026 | Guggenheim | Initiated Coverage | Buy | $50.00 |
| Jan 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $25.00 |

## Frequently Asked Questions

### Is AVTX a buy, sell, or hold?

Analysts covering Avalo Therapeutics currently average a Buy rating: 13 buy, 0 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on AVTX?

On Aug 7, 2026, HC Wainwright & Co. maintained Avalo Therapeutics at Buy with a price target of $30.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).